P
Palisade Bio, Inc.
PALI · NASDAQ · Healthcare · 371M
Closing price
$1.54
+6.21% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
0.7×
Enterprise value / EBITDAEV/EBITDA
2.8×
Free cash flow yieldFCF yield
-12.7%
Return on equityROE
-13.0%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
8.0×
Interest coverage
-1805.6×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.